Your browser doesn't support javascript.
loading
Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement.
Bomken, Simon; Enshaei, Amir; Schwalbe, Edward C; Mikulasova, Aneta; Dai, Yunfeng; Zaka, Masood; Fung, Kent T M; Bashton, Matthew; Lim, Huezin; Jones, Lisa; Karataraki, Nefeli; Winterman, Emily; Ashby, Cody; Attarbaschi, Andishe; Bertrand, Yves; Bradtke, Jutta; Buldini, Barbara; Burke, G A Amos; Cazzaniga, Giovanni; Gohring, Gudrun; De Groot-Kruseman, Hesta A; Haferlach, Claudia; Nigro, Luca Lo; Parihar, Mayur; Plesa, Adriana; Seaford, Emma; Sonneveld, Edwin; Strehl, Sabine; Van der Velden, Vincent H J; Rand, Vikki; Hunger, Stephen P; Harrison, Christine J; Bacon, Chris M; Van Delft, Frederik W; Loh, Mignon L; Moppett, John; Vormoor, Josef; Walker, Brian A; Moorman, Anthony V; Russell, Lisa J.
Afiliação
  • Bomken S; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne. s.n.bomken@newcastle.ac.uk.
  • Enshaei A; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne.
  • Schwalbe EC; Department of Applied Sciences, Northumbria University, Newcastle upon Tyne.
  • Mikulasova A; Biosciences Institute, Newcastle University, Newcastle upon Tyne.
  • Dai Y; Department of Biostatistics, Colleges of Medicine, Public Health and Health Professions, University of Florida, Gainesville, Florida.
  • Zaka M; School of Health and Life Sciences, Teesside University, Middlesbrough, UK; National Horizons Centre, Teesside University, Darlington.
  • Fung KTM; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne.
  • Bashton M; The Hub for Biotechnology in the Built Environment, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne.
  • Lim H; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne.
  • Jones L; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne.
  • Karataraki N; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne.
  • Winterman E; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne.
  • Ashby C; Department of Biomedical Informatics / Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
  • Attarbaschi A; St Anna Children's Hospital, Medical University of Vienna, Vienna.
  • Bertrand Y; Department of Institute of Hematology Oncology Pediatric (IHOP), Hospices Civils de Lyon, Lyon.
  • Bradtke J; Institute of Pathology, Department Cytogenetics, University Hospital Giessen and Marburg.
  • Buldini B; Maternal and Child Health Department, Padua University.
  • Burke GAA; Department of Paediatric Haematology, Oncology, and Palliative Care, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge.
  • Cazzaniga G; School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy; Centro Ricerca Tettamanti, University of Milano-Bicocca, Monza.
  • Gohring G; Department of Human Genetics, Hannover Medical School, Hannover.
  • De Groot-Kruseman HA; Dutch Childhood Oncology Group (DCOG), Utrecht, The Netherlands; Princess Maxima Center for Pediatric Oncology, Utrecht.
  • Haferlach C; MLL Munich Leukemia Laboratory, Munich.
  • Nigro LL; Head of Cytogenetic-Cytofluorimetric-Molecular Biology Laboratory, Center of Pediatric Hematology Oncology, Azienda Policlinico "G. Rodolico - San Marco", Catania.
  • Parihar M; Department of Cytogenetics and Laboratory Haematology, Tata Medical Centre, Kolkata, India.
  • Plesa A; Hematology and Flow cytometry Laboratory, Lyon Sud University Hospital, Hospices Civils de Lyon, Lyon.
  • Seaford E; Department of Paediatric Oncology, Bristol Royal Hospital for Children, Bristol.
  • Sonneveld E; Princess Maxima Center for Pediatric Oncology, Utrecht.
  • Strehl S; St. Anna Children's Cancer Research Institute, Vienna.
  • Van der Velden VHJ; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam.
  • Rand V; School of Health and Life Sciences, Teesside University, Middlesbrough, UK; National Horizons Centre, Teesside University, Darlington.
  • Hunger SP; Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Harrison CJ; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne.
  • Bacon CM; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne.
  • Van Delft FW; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne.
  • Loh ML; Department of Pediatrics, Benioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA.
  • Moppett J; Department of Paediatric Oncology, Bristol Royal Hospital for Children, Bristol.
  • Vormoor J; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom; Princess Maxima Center for Pediatric Oncology, Utrecht.
  • Walker BA; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology Oncology, Indiana University, Indianapolis, IN.
  • Moorman AV; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne.
  • Russell LJ; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne. lisa.russell@newcastle.ac.uk.
Haematologica ; 108(3): 717-731, 2023 03 01.
Article em En | MEDLINE | ID: mdl-35484682
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Linfoma de Burkitt Tipo de estudo: Guideline / Prognostic_studies Limite: Child / Humans Idioma: En Revista: Haematologica Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Linfoma de Burkitt Tipo de estudo: Guideline / Prognostic_studies Limite: Child / Humans Idioma: En Revista: Haematologica Ano de publicação: 2023 Tipo de documento: Article